Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 25Myelodysplastic Syndromes 17Lymphoma, Non-Hodgkin 16Lymphoma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Large B-Cell, Diffuse 14Lymphoma, T-Cell, Peripheral 13Multiple Myeloma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Recurrence 10Leukemia 10Hodgkin Disease 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, T-Cell 7Lymphoma, Follicular 7Hematologic Neoplasms 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Biphenotypic, Acute 6Lymphoma, Extranodal NK-T-Cell 5Leukemia, Myelomonocytic, Chronic 5Primary Myelofibrosis 4Myeloproliferative Disorders 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Immunoblastic Lymphadenopathy 4Prostatic Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

venetoclax 1trametinib 1toripalimab 1tafasitamab 1sonidegib 1ribociclib 1fludarabine 1camrelizumab 1apatinib 1acalabrutinib 1Surveys and Questionnaires 1Rituximab 1R-CHOP protocol 1Lenalidomide 1Immunotherapy, Adoptive 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Cytarabine 1Cyclophosphamide 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pyloric Stenosis, Hypertrophic × Azacitidine × Lymphoid × Clear all
NCT07012447 2025-06-10

Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
32 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Pyloric Stenosis, Hypertrophic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡